Corvus Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2017
Total Assets: $94.8M
Liabilities Breakdown FY2017
Total Liabilities: $9.9M
Asset Breakdown
Total Assets: $94.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $45.1M | 47.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.7M | 2.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $47.0M | 49.6% |
Liabilities Breakdown
Total Liabilities: $9.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.5M | 34.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $6.5M | 65.3% |